Home
Scholarly Works
ACT IV: AN INTERNATIONAL, DOUBLE-BLIND, PHASE 3...
Conference

ACT IV: AN INTERNATIONAL, DOUBLE-BLIND, PHASE 3 TRIAL OF RINDOPEPIMUT IN NEWLY DIAGNOSED, EGFRvIII-EXPRESSING GLIOBLASTOMA

Authors

Weller M; Butowski N; Tran D; Recht L; Lim M; Hirte H; Ashby L; Mechtler L; Goldlust S; Iwamoto F

Volume

18

Pagination

pp. 17-17

Publisher

OXFORD UNIV PRESS INC

Publication Date

November 1, 2016

Name of conference

21st Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology

Conference place

Scottsdale, AZ

Conference start date

November 17, 2016

Conference end date

November 20, 2016

Conference proceedings

NEURO-ONCOLOGY

ISSN

1522-8517

Labels

Fields of Research (FoR)

Contact the Experts team